Table 2.
Tumor and patient characteristics and treatment information of the case series
| Characteristics | No. patients |
|---|---|
| Cancer | |
| Primary | 7 |
| Recurrent | 23 |
| Histological type | |
| Serous | 30 |
| Results of cytoreduction | |
| CC0 | 15 |
| CC1 | 6 |
| CC2 | 4 |
| Unresectable | 5 |
| Peritoneal Cancer Index (mean and range) | 22.7 (6-39) |
| Type of treatment | |
| Carboplatin/taxol | 17 |
| Cisplatin/adriamicin | 6 |
| Carboplatin | 3 |
| Carboplatin/gemcitabine | 2 |
| Carboplatin/taxol/gemcitabine | 2 |
CC0, complete cytoreduction; CC1, minimal residual disease; CC2, maximum residual disease